Neuronetics (STIM) Free Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,539.53% |
| Dec 31, 2025 | 135.93% |
| Sep 30, 2025 | 90.45% |
| Jun 30, 2025 | 78.16% |
| Mar 31, 2025 | -138.00% |
| Dec 31, 2024 | -24.63% |
| Sep 30, 2024 | -0.92% |
| Jun 30, 2024 | 52.97% |
| Mar 31, 2024 | -648.45% |
| Dec 31, 2023 | 123.41% |
| Sep 30, 2023 | 0.18% |
| Jun 30, 2023 | 38.25% |
| Mar 31, 2023 | -333.42% |
| Dec 31, 2022 | 50.73% |
| Sep 30, 2022 | 27.06% |
| Jun 30, 2022 | 25.20% |
| Mar 31, 2022 | -201.34% |
| Dec 31, 2021 | 50.44% |
| Sep 30, 2021 | -57.74% |
| Jun 30, 2021 | 39.84% |
| Mar 31, 2021 | -298.04% |
| Dec 31, 2020 | 33.97% |
| Sep 30, 2020 | 62.41% |
| Jun 30, 2020 | 31.12% |
| Mar 31, 2020 | -103.64% |
| Dec 31, 2019 | 12.11% |
| Sep 30, 2019 | -12.64% |
| Jun 30, 2019 | 29.09% |
| Mar 31, 2019 | -408.95% |
| Dec 31, 2018 | 62.63% |
| Sep 30, 2018 | 4.91% |
| Jun 30, 2018 | 38.14% |
| Mar 31, 2018 | -1,685.61% |
| Dec 31, 2017 | 125.83% |